How to set up product-led growth: step-by-step tutorial for healthcare and life sciences in the United Kingdom

This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in the United Kingdom. In this market, UK buyers reward understatement, credible references, and a pitch that respects their time, so the way you install product-led growth has to be shaped to that reality from day one.

This is the exact sequence we use to install product-led growth when a client says "we want this live by Monday". Product-led growth is using product usage — not a rep — as the primary lead source, and everything below is designed so a single operator can run it end to end.

Step one: write down the account list. If you cannot name 200 companies, you do not yet have a target — you have a demographic. Refine until every account passes a "would we take their money?" gut check.

Step two: define the trigger. What has to be true in the world for you to touch this account this week? For product-led growth, that trigger connects directly to self-serve activation to paid conversion.

Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in the United Kingdom it is compounded by the fact that credibility and reference base, not tooling is what actually gates growth. Product-led growth is only useful here when it is pointed at both constraints at once.

Steps three to five: pick the tools, wire the data, and dry-run against ten accounts. Do not scale until a human has read every artefact and would send it themselves.

Steps six and seven: go live at 20% of intended volume for one week. Track self-serve activation to paid conversion daily, not weekly. Kill anything that misses the bar.

Steps eight to ten: ramp to full volume, publish a Friday review, and set the next 30-day target. Do not chase new tools until the current setup has run for a full month.

The most common tutorial failure is bolting PLG onto a product that requires a demo to understand — usually in step six, when volume feels safe and copy quality slips. Guard step six with a checklist and a second pair of eyes.

Concretely for healthcare and life sciences in the United Kingdom: the healthcare teams that install this get past procurement instead of dying in it, and a single London-anchored win reshapes an entire year of UK pipeline. That is the reason it is worth installing product-led growth deliberately for this market rather than importing a playbook designed for somewhere else.